Electrical Stimulation of Respiratory and Leg Muscles to Improve Lung Function and Restless Leg Syndrome in COPD Patients

What this Trial Is About

This research aims to evaluate the effects of electrical neuromuscular stimulation NMES applied to respiratory and leg muscles on patients with Chronic Obstructive Pulmonary Disease COPD. The study includes patients diagnosed with grade I and grade II COPD who also meet clinical criteria for restless leg syndrome, assessing how this treatment combined with conventional pulmonary rehabilitation may impact pulmonary function and leg symptoms. Participants are divided into two groups one receives active NMES with specific electrical pulses applied to the quadriceps and intercostal muscles along with a pulmonary rehabilitation program that includes breathing exercises the other group receives placebo NMES at the same locations along with the same rehabilitation program. The stimulation is delivered by electrode patches placed on targeted muscle areas, and the treatment is given over a 10-week period. Throughout the study, participants undergo evaluations including the dynamic gait index, pulmonary function tests, dyspnea assessment, restless leg syndrome questionnaires, sleep quality measurement, and chronic respiratory disease questionnaires. These assessments occur at the start and end of the 10 weeks to monitor changes. The study also ensures monitoring for safety and adherence, with participation expected to last around 10 weeks.

Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients